Evommune, Inc.

NYSE:EVMN

Biotechnology

Healthcare
$7.02 -0.82%

-$0.17 today

Market cap
$290.28M
Beta
0.10
P/E (TTM)
-9.1
EPS (TTM)
-$2.26
52W Low $13.89High $33.20

Volume 0.90M

Average 0.38M

Price history

Evommune, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-65.23%

Period high

$31.57

Period low

$5.10

Latest

$7.02

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
424B3Nov 12, 2026Nov 12, 2026
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
SC 13D/ANov 10, 2026Nov 10, 2026
8-KNov 5, 2026Nov 5, 2026
424B3Nov 4, 2026Nov 4, 2026
8-KNov 4, 2026Nov 4, 2026
4Oct 15, 2026Oct 15, 2026
8-KOct 1, 2026Oct 1, 2026
8-KSep 23, 2026Sep 23, 2026
8-KSep 15, 2026Sep 15, 2026
424B3Sep 9, 2026Sep 8, 2026
8-KSep 9, 2026Sep 8, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026

Competitors

Who does Evommune, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about EVMN's filings, answered from its disclosures.

What is the latest EVMN filing?

The latest filing shown is 424B3 dated Nov 12, 2026.

How many recent filings does EVMN have?

Intrinsic Alpha currently shows 20 recent filings for EVMN.